98%
921
2 minutes
20
: In this study, we review the diagnostic accuracy of magnetic resonance imaging (MRI) in detecting orbital and intracranial invasion of sinonasal malignancies (SNMs) using histopathological and surgical evidence as the reference standard. : A systematic search of studies in English was conducted in MEDLINE and Embase, limited to articles published since 1990. We included studies using preoperative MRI to detect the intracranial and orbital invasion of SNMs, with histological or surgical confirmation as the reference standard, and reported patient numbers in each class as required to assess diagnostic accuracy. The outcome measures were sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Heterogeneity was assessed with the Higgins inconsistency test (). : Seven original articles with 546 subjects were included in the review, with six included in the meta-analysis. The pooled overall accuracy for orbital invasion was higher at 0.88 (95% CI, 0.75-0.94) than that for intracranial invasion at 0.80 (95% CI, 0.76-0.83). The meta-analytic estimates and their 95% confidence intervals were as follows for intracranial/orbital invasion: sensitivity 0.77 (0.69-0.83)/0.71 (0.40-0.90); specificity 0.79 (0.74-0.83)/0.91 (0.78-0.97); PPV 0.76 (0.64-0.85)/0.78 (0.61-0.88); and NPV 0.82 (0.72-0.89)/0.90 (0.63-0.98). Substantial heterogeneity was observed in the Higgins inconsistency test () for orbital invasion (84%, 83%, and 93% for sensitivity, specificity, and NPV, respectively). : MRI yielded moderate-to-high diagnostic accuracy for intracranial and orbital invasion, despite some limitations leading to false diagnoses. Loss of the hypointense zone on postcontrast MRI was found to predict dural invasion. Infiltration of the extraconal fat beyond the periorbita was found to be an MRI feature of orbital invasion.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11728326 | PMC |
http://dx.doi.org/10.3390/jcm13247556 | DOI Listing |
MedComm (2020)
September 2025
Cancer metabolic reprogramming is a fundamental hallmark that enables tumor cells to sustain their malignant behaviors. Beyond its role in supporting growth, invasion, and migration, metabolic rewiring actively contributes to anticancer drug resistance. Cancer cells not only reshape their own metabolism but also engage in aberrant metabolic crosstalk with nonmalignant components within the tumor microenvironment (TME).
View Article and Find Full Text PDFJ Surg Case Rep
September 2025
Department of Otolaryngology Head and Neck Surgery, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia.
A variety of pathologies and anatomical variations contribute to the underreporting of pediatric paranasal sinus disorders. The frontal sinus presents significant risk for complications due to its proximity to the orbit and brain. Three cases encountered in a tertiary hospital are discussed in this study to illustrate the usefulness of endonasal endoscopic methods in addressing pediatric frontal sinus lesions.
View Article and Find Full Text PDFCancer Diagn Progn
September 2025
Institute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Background/aim: Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by the development of multiple tumors, including plexiform neurofibromas (PNFs), which often affect the craniofacial region and cause significant functional and aesthetic impairments. This report presents long-term surgical management of a patient with hemifacial diffuse PNF, complicated by the emergence of a rapidly enlarging midfacial tumor.
Case Report: The patient was treated for hemifacial invasive diffuse plexiform neurofibroma.
Vestn Otorinolaringol
September 2025
National Medical Research Center of Radiology, Obninsk, Russia.
Primary squamous cell carcinoma of the orbit is rare, as this area does not have its own squamous epithelium. Tumors of this localization are caused either by the germination of the primary focus located on the skin of the face or in the paranasal sinuses, or by the spread of the tumor through perineural invasion. The difficulty of surgical treatment of this localization is that with standard access it is often impossible to visualize the posterior edge of the resection, which, in turn, can lead to a recurrence of the tumor process.
View Article and Find Full Text PDFOrbit
September 2025
Adnexal, Moorfields Eye Hospital, London, UK.
Purpose: To evaluate the real-world efficacy, safety, and outcomes of cemiplimab for advanced periocular conjunctival and cutaneous squamous cell carcinoma (SCC).
Methods: Retrospective case series of adults treated with cemiplimab for periocular conjunctival or cutaneous SCC at Moorfields Eye Hospital (2021-2025).
Results: We included 9 patients (mean age 66, range 43-79; 56% female; 78% Caucasian).